The Lovelace Biomedical Podcast

5 Episodes

Reverse

Medical Countermeasure Drug Development - with Melanie Doyle-Eisele, PhD

2022-03-2322:07

Jake sits down with our Director of Life Sciences, Melanie Doyle-Eisele, PhD to talk about what's inside Medical Countermeasure drug development. Oh, and Girl Scout cookies.

Armchair Quarterback: Public Health Perspective to SARS/COVID The Pandemic Response, An Interview with Dr. Robert Amler, School of Public Health at New York Medical College

2022-03-0937:42

Jake talks about the public health perspective with regards to covid19 and the pandemic, with Dr. Robert Amler, from the School of Public Health at New York Medical College

Use of Biomarkers to determine Immune Response in Drug Development

2022-02-2317:47

On this week's episode, Jake talks to Dharmesh Desai, our Director of Immunology & Large Molecule Bioanalysis. Biomarkers and assays within drug development. How it works, and why it's important.

Targeting the CNS System in Gene Therapy

2022-02-1027:29

Jake McDonald PhD, Rachel Cooper DVM, MS, DACLAM , and Jane Lindborg discuss assessments in CNS targeting and dosing for gene therapy applications. Listen to and download materials from a fantastic past webinar on this topic: https://www.multivu.com/players/English/8984851-lovelace-biomedical-webinar-neuroscience-gene-therapy-nonclinical-development/

Inhaled Delivery, and Targeting Infectious Disease

2022-01-2018:20

Jake McDonald, PhD, VP Applied Sciences, Philip Kuehl, PhD, and Meghan Vermillion, DVM, PhD, DACLAM, Director of Comparative MedicineOur first episode! We talk about infectious diseases, and inhaled delivery to target and treat diseases.

#box-pro-ellipsis-176206282641397{-webkit-line-clamp:2;}The Lovelace Biomedical Podcast